You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Maraviroc

Showing 1 - 25 of 162
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Post-stroke Depression Trial in Tel Aviv (Maraviroc 300 mg)

Completed
  • Post-stroke Depression
  • Maraviroc 300 mg
  • Tel Aviv, Israel
    Tel Aviv Sourasky Medical Center
Jun 28, 2023

COVID-19 Trial in Mexico City (Maraviroc + Currently used therapy, Curently used therapy for COVID-19 non-critical patients,

Terminated
  • COVID-19
  • Maraviroc + Currently used therapy
  • +3 more
  • Mexico City, Cdmx, Mexico
    Hospital General de México "Dr. Eduardo Liceaga"
May 31, 2022

HIV, Hematologic Malignancies Trial run by the National Cancer Institute (NCI) (RIC, GVHD prophylaxis, allo HCT)

Not yet recruiting
  • HIV
  • Hematologic Malignancies
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

COVID-19 Trial in Barcelona, Madrid (Maraviroc 300 mg, Standard care therapy)

Terminated
  • COVID-19
  • Maraviroc 300 mg
  • Standard care therapy
  • Barcelona, Spain
  • +1 more
Feb 24, 2022

Metastatic Colorectal Cancer, MSS Trial in Heidelberg (Pembrolizumab, Maraviroc)

Completed
Has Results
  • Metastatic Colorectal Cancer
  • MSS
  • Pembrolizumab
  • Maraviroc
  • Heidelberg, Germany
    National Center for Tumor Diseases, University Hospital Heidelbe
May 17, 2022

HIV Trial in Baltimore (Switch to Maraviroc + Raltegravir or Dolutegravir)

Completed
Has Results
  • HIV
  • Switch to Maraviroc + Raltegravir or Dolutegravir
  • Baltimore, Maryland
    University of Maryland, Institute of Human Virology
Oct 5, 2021

HIV Trial in Worldwide (Maraviroc)

Completed
Has Results
  • HIV Infections
  • Maraviroc
  • Los Angeles, California
  • +8 more
Dec 30, 2021

Stroke Trial in Canada (drug, behavioral, other, device)

Not yet recruiting
  • Stroke
  • Maraviroc
  • +4 more
  • Vancouver, British Columbia, Canada
  • +6 more
May 2, 2022

Virus Diseases Trial in Sevilla (Maraviroc experimental group, Standard treatment)

Completed
  • Virus Diseases
  • Maraviroc experimental group
  • Standard treatment
  • Sevilla, Spain
  • +1 more
Oct 15, 2021

AIDS Dementia Complex Trial in Honolulu, San Juan (Maraviroc, Placebo)

Completed
  • AIDS Dementia Complex
  • Maraviroc
  • Placebo
  • Honolulu, Hawaii
  • +1 more
Aug 27, 2021

Post Stroke Cognitive Impairment Trial in Tel Aviv (Maraviroc)

Recruiting
  • Post Stroke Cognitive Impairment
  • Maraviroc
  • Tel Aviv, Israel
    Tel Aviv Sourasky Medical Center
Jul 14, 2021

Stroke Trial in Los Angeles, New Haven, White Plains (Maraviroc 300 mg, Rehabilitation therapy, Placebo 300 mg)

Terminated
Has Results
  • Stroke
  • Maraviroc 300 mg
  • +2 more
  • Los Angeles, California
  • +2 more
Jul 12, 2021

Hepatic Steatosis, HIV-1-infection Trial in London (Maraviroc, Metformin)

Completed
  • Hepatic Steatosis
  • HIV-1-infection
  • London, United Kingdom
  • +5 more
Nov 3, 2021

HIV Infection Trial in Puerto Rico, United States (Maraviroc, Emtricitabine, Tenofovir disoproxil fumarate)

Completed
Has Results
  • HIV Infection
  • Maraviroc
  • +5 more
  • Los Angeles, California
  • +12 more
Nov 3, 2021

HIV Trial in Worldwide (Placebo for maraviroc (MVC), Placebo for dolutegravir (DTG), Dolutegravir (DTG))

Completed
Has Results
  • HIV Infections
  • Placebo for maraviroc (MVC)
  • +3 more
  • Los Angeles, California
  • +29 more
Apr 20, 2022

COVID Trial in Providence (Maraviroc)

Completed
  • COVID
  • Maraviroc
  • Providence, Rhode Island
    Rhode Island Hospital
Feb 2, 2021

Kaposi's Sarcoma Trial in San Francisco (Maraviroc)

Completed
Has Results
  • Kaposi's Sarcoma
  • Maraviroc
  • San Francisco, California
    San Francisco General Hospital, Clinical Trials Unit
Mar 3, 2021

Colorectal Cancer Metastatic, Pancreatic Cancer Metastatic Trial in Heidelberg (Nivolumab plus Ipilimumab plus Maraviroc)

Active, not recruiting
  • Colorectal Cancer Metastatic
  • Pancreatic Cancer Metastatic
  • Nivolumab plus Ipilimumab plus Maraviroc
  • Heidelberg, Germany
    University of Heidelberg / NCT
Jan 20, 2021

Hematologic Malignancy Trial in Philadelphia (Maraviroc 300 mg)

Completed
Has Results
  • Hematologic Malignancy
  • Maraviroc 300 mg
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Dec 16, 2020

HIV Trial in Philadelphia (lopinavir/ritonavir plus maraviroc)

Terminated
Has Results
  • HIV Infections
  • lopinavir/ritonavir plus maraviroc
  • Philadelphia, Pennsylvania
    Temple General Internal Medicine
Oct 8, 2020

HIV Infection Trial in Torino (maraviroc (300 mg QD) + atazanavir/ritonavir (300 and 200 mg /100 mg QD))

Withdrawn
  • HIV Infection
  • maraviroc (300 mg QD) + atazanavir/ritonavir (300 and 200 mg /100 mg QD)
  • Torino, Italy
    University of Torino
Nov 5, 2020

HIV-1-infection Trial in London (Maraviroc, Truvada)

Completed
  • HIV-1-infection
  • London, Greater London, United Kingdom
    Guy's & St. Thomas' NHS Foundation Trust
Jul 16, 2021

HIV Infection Trial in United States (Placebo, Maraviroc)

Completed
Has Results
  • HIV Infection
  • Placebo
  • Maraviroc
  • San Francisco, California
  • +3 more
Jul 23, 2020

HIV-1 Infection Trial in Puerto Rico, United States (Darunavir, Ritonavir, Tenofovir disoproxil fumarate)

Completed
Has Results
  • HIV-1 Infection
  • Birmingham, Alabama
  • +37 more
Jul 31, 2021

Diagnoses That Require Stem Cell Transplant, GVHD (GVHD) Trial in Cincinnati (Maraviroc)

Terminated
Has Results
  • Diagnoses That Require Stem Cell Transplant
  • Graft Versus Host Disease (GVHD)
  • Maraviroc
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Mar 2, 2020